Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Evangelos Oikonomou MD, DPhil

Evangelos Oikonomou MD, DPhil

Cardiovascular Medicine Fellow, Physician-Scientist Training Program, Yale University, New Haven, Connecticut

Evangelos Oikonomou is a clinical fellow in cardiovascular medicine and a member of the ABIM Physician-Scientist Research Pathway at Yale School of Medicine. He holds a medical degree from the University of Athens, Greece, and a PhD (D.Phil.) in Medical Sciences from the University of Oxford, United Kingdom. As a PhD student in Oxford (Division of Cardiovascular Medicine, Radcliffe Department of Medicine), Evangelos investigated the biological interplay between the perivascular adipose tissue and the human vasculature. During the course of his project "Non-invasive phenotyping of perivascular adipose tissue for cardiovascular disease diagnosis and risk stratification", he developed machine learning-based non-invasive imaging approaches to better characterize the role of perivascular inflammation in atherosclerosis. As a physician-scientist at Yale and a member of the Cardiovascular Data Science (CarDS) Lab (led by Dr Rohan Khera), he is interested in applying machine learning approaches using multiple data types (imaging, EHR and clinical trial data) to personalize the diagnosis and treatment of cardiovascular disease.

Disclosures

Dr. Oikonomou is an academic co-founder and consultant of Evidence2Health, LLC, a machine learning health analytics company. He is named as a co-inventor in a U.S. Provisional Patent Application (“Methods For Neighborhood Phenomapping For Clinical Trials”, No. 63/177,117 filed April 20, 2021). He has also acted as a consultant for Caristo diagnostics Ltd (Oxford, United Kingdom) and is named as a co-inventor in patents relating to the radiomic phenotyping of pericoronary adipose tissue for cardiovascular diagnosis and risk stratification.